Han Jin Cho Selected Research

Han Jin Cho Research Topics

Disease

13	Neoplasms (Cancer) 05/2017 - 08/2003
10	Colonic Neoplasms (Colon Cancer) 09/2014 - 01/2003
7	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 10/2006
5	Stroke (Strokes) 07/2021 - 11/2010
4	Edema (Dropsy) 11/2014 - 12/2009
3	Neoplasm Metastasis (Metastasis) 05/2017 - 05/2012
3	Adenocarcinoma 01/2016 - 02/2011
2	Ischemic Stroke 07/2021 - 11/2010
2	Hypoxia (Hypoxemia) 05/2017 - 05/2012
2	Infections 05/2017 - 04/2005
2	Inflammation (Inflammations) 11/2014 - 01/2008
2	Carcinogenesis 02/2011 - 08/2003
2	Hypertension (High Blood Pressure) 09/2010 - 01/2009
1	Osteoporosis 12/2021
1	Atrial Fibrillation 07/2021
1	Lymphatic Metastasis 05/2017
1	Melanoma (Melanoma, Malignant) 05/2017
1	Wounds and Injuries (Trauma) 05/2017
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2016
1	Breast Neoplasms (Breast Cancer) 11/2015
1	Body Weight (Weight, Body) 11/2015
1	Transient Ischemic Attack 08/2015
1	Pathologic Constriction (Stenosis) 08/2015
1	Prostatic Intraepithelial Neoplasia 04/2015
1	Carcinoma (Carcinomatosis) 04/2015
1	Obesity 01/2015
1	Human Influenza (Influenza) 01/2015
1	Thrombosis (Thrombus) 04/2014
1	Myocardial Infarction 11/2010
1	Hemorrhage 11/2010

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2015 - 12/2005
6	Conjugated Linoleic AcidsIBA 02/2010 - 01/2003
4	LipidsIBA 05/2017 - 01/2015
4	CytokinesIBA 04/2015 - 05/2012
4	LipopolysaccharidesIBA 11/2014 - 01/2008
4	IGF Type 1 Receptor (IGF 1 Receptor)IBA 09/2014 - 08/2003
3	3,3',4,5'-tetrahydroxystilbeneIBA 11/2015 - 12/2008
3	kaempferolIBA 09/2014 - 09/2013
3	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 04/2006 - 01/2003
2	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 11/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 08/2003
2	benzyl isothiocyanateIBA 01/2016 - 01/2015
2	Macrophage Colony-Stimulating FactorIBA 01/2015 - 01/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014 - 05/2012
2	Anticarcinogenic AgentsIBA 09/2013 - 02/2010
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2012 - 01/2003
2	StilbenesIBA 11/2009 - 12/2008
2	isoliquiritigenin (GU 17)IBA 09/2009 - 10/2006
1	LigandsIBA 12/2021
1	Leucine (L-Leucine)FDA Link 12/2021
1	AnticoagulantsIBA 07/2021
1	N(4)-oleylcytosine arabinosideIBA 07/2021
1	Vitamin K FDA Link 07/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017
1	oleuropeinIBA 05/2017
1	cadherin 5IBA 05/2017
1	Vascular Endothelial Growth Factor CIBA 05/2017
1	Vascular Endothelial Growth Factor DIBA 05/2017
1	Macrophage Migration-Inhibitory FactorsIBA 05/2017
1	C-Reactive ProteinIBA 05/2017
1	glucotropeolinIBA 01/2016
1	Cyclin AIBA 11/2015
1	Cyclin D1IBA 11/2015
1	Caspase 3 (Caspase-3)IBA 11/2015
1	Transcription Factors (Transcription Factor)IBA 11/2015
1	lardIBA 04/2015
1	Conditioned Culture MediaIBA 04/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 01/2015
1	ChemokinesIBA 01/2015
1	Nucleic AcidsIBA 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	berteroinIBA 11/2014
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2014
1	glucoerucinIBA 10/2013
1	erucinIBA 10/2013
1	isothiocyanic acidIBA 10/2013
1	Phorbol EstersIBA 10/2013
1	3-hydroxyflavoneIBA 09/2013
1	TeaIBA 09/2013
1	JNK Mitogen-Activated Protein KinasesIBA 05/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2013
1	Protein Kinase CIBA 05/2013
1	licochalcone EIBA 05/2013
1	Mitogen-Activated Protein Kinase 3IBA 05/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2013
1	LuteolinIBA 01/2012
1	3,3'-diindolylmethane (diindolylmethane)IBA 02/2011
1	Death Domain ReceptorsIBA 02/2011
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2011
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2010

Therapy/Procedure

3	Stents 06/2017 - 04/2014
2	Therapeutics 07/2021 - 09/2014
1	Length of Stay 05/2017
1	Carotid Endarterectomy 01/2016
1	Oral Administration 11/2015
1	Nanospheres 01/2015
1	Thrombectomy 04/2014